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Human  peripheral blood  lyrnphocytes are  made  up  of  two  major  populations, 
characterized by functional differences and different cell surface markers. Lymphocytes 
belonging to the bone marrow-derived population (B cells) have easily detectable im- 
munoglobulin  on  their  surface  (1).  In  addition  they  have  receptors for  antigen/ 
antibody complexes or aggregated immunoglobulin (Fc receptors)  (2)  and receptors 
for  the  complement  component  C3  (3).  Human  T  cells may be  detected by their 
ability to form spontaneous rosettes with sheep erythrocytes (4). Plant lectins such 
as concanavalin A  (Con A) and phytohemagglutinin (PHA)  bind to both B  and T 
cells but induce stimulation of DNA synthesis and blast transformation primarily in 
the latter population (5). However, the latter property depends partly on the condi- 
tions of stimulation, and B-cell stimulation by these agents has also been reported 
(6). Mouse T  cells are also characterized by their more pronounced anodic mobility 
in  the  electric  field,  ascribable  to  their  elevated  concentration  of  surface-bound 
N-acetyl neuraminic acid (7). 
In  contrast  to  Con  A  and  PHA,  the  hemagglutinin  from  the  snail Helix 
pomatia (Helix pomatia A  hemagglutinin) does not interact with untreated hu- 
man blood lymphocytes as determined by binding experiments (8). In this study 
we demonstrate (a) that human blood lymphocytes after treatment with neura- 
minidase will bind Helix pomatia  A  hemagglutinin,  (b)  that  the  binding cells 
most probably are T  cells, and  (c)  that the binding properties of the cells can 
be utilized for fractionation of lymphocyte subpopulations. 
Materials  and Methods 
Human peripheral blood lymphocytes were obtained from the blood of healthy donors by 
defibrination and gelatin sedimentation.  After removal of phagocytic cells with colloidal iron 
they were further purified by centrifugation through a layer of Ficoll-Isopaque  (9). These pro- 
cedures resulted in leukocyte preparations consisting  to >  98%  of lymphocytes, containing 
5-10% of contaminating erythrocytes. In this study, donors of blood group A were excluded 
in order to avoid reactions between the hemagglufinin and contaminating A erythrocytes (8). 
To create hemagglutinin  receptors, purified lymphocytes were treated with neuraminidase 
from Clostrldium perfringens [type VI, 1-3 U/rag (NAN-lactose substrate), Sigma Chemical 
Co., St. Louis, Mo.] at 37°C for 45 rain. 25.106 lymphocytes in 1 ml of Tris-buffered  Hanks' 
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solution (TH) were mixed with 1 ml of TH containing 10/~g of neuraminidase. The cells were 
then spun down and washed once in TH (cell recovery 80-90%). Binding experiments were 
performed with cells in TH containing 0.1% human serum albumin (HSA). In the fractiona- 
tion experiments the cells were suspended in N-2-hydroxyethylpiperazine-NP-2-ethane  sulfonic 
acid (HEPES)-buffered medium RPMI 1640 (Bio Cult Laboratories, Paisley, Scotland)  con- 
taining 0.1% HSA and cells were also stored in this medium at 4°C. Neuraminidase-treated 
cells were >  95% viable as assessed by vital staining with trypan blue. When incubated with 
PHA, stimulation of DNA synthesis was more pronounced than what was seen in the untreated 
controls (unpublished data). 
Highly purified Helix pomatia A hemagglutinin was prepared by immunospecific purifica- 
tion on insolubilized hog A +  H blood group substance (10). The material was homogenous 
by several physicochemical  criteria and was completely precipitated by blood group A sub- 
stance. The hemagglutinin has a tool wt of 79,000 +  4,000 (11). It is made up of six identical 
or closely similar subunits, each containing one carbohydrate binding site. The binding site 
interacts most strongly with methyl-~x-N-acetyl-D-galactosamine (Me-a-D-GalNAc),  followed 
by methyl-a-N-acetyl-D-glucosamine (Me-a-D-GNAc) N  Me-~-D-GalNAc >> Me-fl-D-GNAc 
>  Me-a-D-galactose  (10, 12-14). 
For binding studies, the hemagglutinin was trace-labeled  with carrier-free [125I]Na (Radio- 
chemical Center, Amersham,  England), using the chloramine-T procedure  (8,15). The cell- 
binding experiments were performed with a constant number of cells and increasing amounts 
of labeled hemagglutinin. The binding data were treated according to Scatchard's derivation 
of the law of mass action. The calculated K value is an apparent association  constant reflecting 
the effect of multivalent interaction between hemagglutinin and cell. Earlier studies suggested 
that intact hemagglutinin is bound at least trivalently to human A erythrocytes (8). 
In immunofluorescence  experiments,  the hemagglutinin was labeled with fluorescein iso- 
thiocyanate (FITC) on Celite (16). The fluorescein to protein molar ratio was 6.0. The exper- 
iments were carried out at room temperature with living cells in TH containing 0.02% NaN 3 • 
RESULTS AND  DISCUSSION 
We first studied the effect of neuraminidase treatment on the appearance of 
receptors for Helix pomatia  A  hemagglutinin.  25.106  cells, incubated  for  45 
rain with  10 and 100/~g of neuraminidase, respectively, bound approximately 
the same number of hemagglutinin molecules per cell at saturation (7-106 and 
11.105,  respectively) as determined by means of ~5I-labeled hemagglutinin.  1 
#g of neuraminidase/25,106  cells was not sufficient to create detectable num- 
bers of hemagglutinin  receptors during  this  incubation  period.  10 ~g/25. l0  s 
cells was chosen for all subsequent experiments. Fig. 1 shows the binding curves 
for  lymphocytes from  two  different  donors  and  for neuraminidase-treated O 
erythrocytes from  one  of  these.  Assuming uniform  binding  to  all cells,  (see, 
however, below), each lymphocyte bound approximately 1-106 hemagglutinin 
molecules and each erythrocyte approximately 0.3.106  molecules. The binding 
curves are drawn as straight lines, calculated by the method of least squares. 
The  apparent  K  values  were  5-7. l0  s  liter/mol  for lymphocytes and 0.5.10  s 
liter/tool  for  erythrocytes,  respectively.  However,  it  should  be  noted  that 
the binding curves for lymphocytes may not  be linear. It would appear  that 
the number of hemagglutinin receptors of neuraminidase-treated lymphocytes 
is  similar  to  that  of  human  A1  erythrocytes  (8).  The  apparent  association 
constant  is,  however,  two  orders  of  magnitude  lower.  Assuming  trivalent 
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FIG. 1. Binding of 12~I-labeled Helix pomatia A hemagglutinin to neuraminidase-treated 
human lymphocytes (1.2-106/ml) from two different donors (Ly) and  to neuraminidase- 
treated human O erythrocytes (1.5-106/ml) from one of these donors (RBC). Data plotted 
according to Scatchard's derivation of the law of mass action (see text). 
structure responsible for binding of the hemagglutinin  is  not a-linked 9-Gal- 
NAc as in the A determinant of the erythrocytes. The chemical  nature of the 
lymphocyte receptor  is  not  known.  Possible candidates  are nonreducing a- 
linked D-GNAc or  /~-linked D-GalNAc (8,  10,  12-14). However, differences in 
spacing of the receptors or different influences of secondary binding forces may 
be responsible for the differences in avidity of binding. 
Immunofluorescence studies  of living,  neuraminidase-treated  lymphocytes 
from  healthy  donors,  using  FITC-conjugated  hemagglutinin,  demonstrated 
that only approximately 60% of the lymphocytes showed membrane fluores- 
cence (Fig. 2 a). The percentage positively staining cells in lymphocyte prepa- 
rations from five different blood donors (five experiments) varied from 58 to 
73 %. As seen from Fig.  2 a, :increasing the conjugate concentration above a 
certain level did not increase the percentage of positive cells.  The figure also 
shows  that  cells not  treated with  neuraminidase  are  negative and  that pro- 
longed neuraminidase  treatment  did not increase  the percentage of positive 
cells.  Staining is specific as demonstrated by inhibition with D-GalNAc and by 
the absence of significant inhibition with comparable concentrations of L-fucose 
(8). 
Fig.  2 b  shows  the  percentage  of  cells  with  positive membrane  immuno- 
fluorescence after staining with FITC hemagglutinin of two lymphocyte prepa- 
rations (two donors), enriched in T lymphocytes. Enrichment was accomplished 
by passage through columns filled either with glass beads or with Degalan beads 
(polymethylmeta acrylate,  type  W-26;  Degussa  Wolfgang  AG, Hanau  am 
Main, W.  Germany) and charged with human immunoglobulin G and rabbit 
antihuman immunoglobulin (17) or with activated C3, respectively.  1 Immuno- 
fluorescent staining for surface-bound immunoglobulin demonstrated that the 
passed preparations were deprived of B lymphocytes. Their content of lympho- 
cytes with complement receptors was significantly reduced as indicated by their 
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FIG. 2. Immunofluorescent staining of neuraminidase-treated human lymphocytes with 
FITC-conjugated Helix pomatia A hemagglutinin (0.5-106 lymphocytes, 50 #1 of FITC he- 
magglufinin, 20 rain). Ordinate: percent of cells  showing  positive membrane  fluorescence.  Abs- 
cissa: dilution of FITC hemagglutinin, original concentration 0.75 mg/ml. (a) (m) untreated 
lymphocytes; (0) lymphocytes treated with neuraminidase for 45 rain; (O) treated for 90 
rain; (X) neuraminidase-treated lymphocytes (45 rain) in the presence of either D-GalNAc 
(200 #g) or L-Fuc (200 /zg). Vertical bar indicates range of percent positive cells in neura- 
minidase-treated  lymphocytes  from five different  donors  (see text). (b) (O) lymphocytes  passed 
through column charged with human gamma globulin (HGG)/anfi-HGG and treated with 
neuraminidase; (~) lymphocytes  passed through C3 column and treated with neuraminidase; 
(A) neuraminidase-treated  lymphocytes from patient with multiple myeloma. 
strongly diminished capacity to form rosettes with complement-coated sheep 
erythrocytes (EAC) (3). Furthermore, the antibody-induced cytotoxicity of the 
passed cells against 51Cr-labeled chicken erythrocytes (Crbc) was very strongly 
reduced, thus indicating  that  the passed  cell preparations were  significantly 
depleted of cells with Fc receptors (9). As seen from Fig. 2 b about 90 % of the 
passed cells were stained with FITC Helix hemagglutinin. In contrast, a sample 
of purified lymphocytes from a patient with multiple myeloma, containing a 
high percentage of B cells (56 % as determined by rosette formation with EAC, 
50%  by immunofluorescent staining  with  anti-Ig),  gave approximately 40% 
cells stained with FITC hemagglutinin. The results indicate that the lympho- 
cytes that bind the hemagglutinin after treatment with neuraminidase belong 
to the thymus-derived variety. 
In  further  studies  we  attempted  to  use  the  hemagglutinin  to  physically 
separate reactive and nonreactive lymphocytes. Degalan beads were coated with 
hog blood group A +  H  substance, washed, and packed in a column (0.5 X  14 
cm) charged with different amounts of unlabeled hemagglutinin (supplemented 
with  some  125I-labeled material)  in  TH.  After  extensive washing  with  TH, 
followed by RPMI 1640 HEPES (containing 0.1% HSA), lymphocyte suspen- 
sions were passed through the columns. These were immediately washed with 
medium,  followed by elution  with  medium  containing 0.1%  D-GalNAc.  All 
operations were performed with ice-chilled solutions.  The passed  and eluted 
cells were spun down and counted. In order to remove adsorbed hemagglutinin, 
they were  subsequently washed with  medium  containing D-GalNAc.  Radio- 
activity determinations demonstrated that less  than 0.5  ng of hemagglutinin 
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results of one experiment in which the column was charged with 16.106 lympho- 
cytes are shown in Table I. As may be seen, the percentage of cells giving posi- 
tive staining with FITC hemagglutinin was significantly lower in  the passed 
fraction  than  in  the  fraction  eluted  with  D-GalNAc,  or  in  the  cells  passed 
through the control column, charged only with blood group substance. In other 
experiments  in  which  the  cells  were  tested  for  their  capacity to  form EAC 
rosettes,  the  percentage  of complement receptor lymphocytes (CRL)  in  the 
passed cells was 40-50 % as compared with 15-20 % in the control. In contrast 
the D-GalNAc-eluted fraction was more or less completely depleted of CRL. As 
seen from Table I, the best separation was achieved with an intermediate con- 
centration of hemagglutinin on the column. In this case the total cell recovery 
was approximately 50 %. Incubation of the column with D-GalNAc for 5 rain 
before elution increased the yield of FITC hemagglutinin-positive cells  eluted 
from the  column. We conclude that  these procedures permit a  separation  of 
thymus-derived from  thymus-independent lymphocytes in human peripheral 
blood. Further work is needed to increase the degree of separation. 
SUMMARY 
Neuraminidase treatment of human peripheral blood lymphocytes uncovers 
cell  surface receptors that bind purified A hemagglutinin from the snail Helix 
pomatia.  No  hemagglutinin  was  bound  to  untreated  lymphocytes.  Binding 
studies with 125I-labeled hemagglutinin suggested that the number of receptors 
on neuraminidase-treated lymphocytes was approximately 1.106/cell.  The ap- 
parent  association  constant  for  hemagglutinin  binding  to  lymphocytes,  as 
calculated from Scatchard's plots, was 5-7. l0  s liters/mol. 
Immunofluorescent staining with FITC-conjugated hemagglutinin gave posi- 
tive reactions with approximately 60 % of the lymphocytes from normal donors. 
Positive staining was inversely related to the number of lymphocytes with Fc 
or complement receptors or with surface immunoglobulin, thus suggesting that 
TABLE I 
Fractlonation  of  Neuraminidase-Treated  Human  Lymphocytes  on  Degalan  Bead  Columns 
Charged with Hog Blood Group A  +  H  Substance  and  Helix pomatia  A  Hemagglutinin* 
Beads charged with 
Cells staining with FITC  Cells  recovered  heraagglutinin 
Passed  D-GalNAc  Passed  D-GalNAc 
eluate  eluate 
%  % 
Hog A +  H substance +  416 #g hemagglutinin  1  23  n.d.~  58 
....  +  ....  +  66#g  "  6  43  13  61 
"  "  +  "  "  +  20#g  "  27  55  46  73 
Hog A +  H substance  90  0  73  -- 
* Packed Degalan beads were incubated with an equal volume of hog blood group A +  H 
substance (0.5 mg/ml) for 18 h in the cold, washed extensively with TH, and packed in 
columns. The columns were charged with the  indicated amounts of hemagglutinin and 
washed extensively before application of 16  X  106 lymphocytes. For other experimental 
details see text. 
:~ n.d. = not done. HAMMARSTROM  ET AL.  BRIEF DEFINITIVE REPORT  1275 
the lymphocytes with receptors for Helix pomatia A hemagglutinin are T  cells, 
Cell fractionafion on columns charged with hemagglutinin indicate that these 
receptors  may  be  used  for  separating  subpopulations  of  human  peripheral 
lymphocytes. 
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